Orthocell Ltd has released a press release.
Orthocell Receives A$2.5m R&D tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- CelGro Used as Artificial Periosteum Repairs Bone
- CelGro used in Nano Medicine Breakthrough
- Preliminary Final Report and Annual Financial Statements
- OCC Reports First Product Use and Sales of CelGro in Ireland
- CelGro Pre-Submission Meeting Completed with the FDA
Later from Orthocell
- Successful CelGro Results Presented at Key Euro Conference
- Orthocell Secures CelGro Patent Protection in Japan
- Investor Update
- OCC Receives New Patents for Celgro Platform Technology
- Patient Treatment Completed in Dental Implant Study
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell